Skip to content

Author

Shu-Kai Gu

We have 5 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

PepPCBench is a Comprehensive Benchmarking Framework for Protein-Peptide Complex Structure Prediction

PepPCBench enables a robust evaluation of PFNN-based methods and supports their continued development for peptide-protein structure prediction, and highlights the influence of peptide length, conformational flexibility, and training set similarity on prediction accuracy.

Si-Long Zhai, Huifeng Zhao, Ji-Ke Wang et al. · 13 citations · ⚡1

CarsiDock-Cov: A deep learning-guided approach for automated covalent docking and screening

CarsiDock-Cov is presented, a new paradigm distinguishing itself as the first deep learning (DL)-guided approach for covalent docking, offering an automated and efficient solution that shows considerable promise for accelerating covalent drug discovery and design.

Chao Shen, Hongyan Du, Xujun Zhang et al. · 12 citations
#natural language process... Open access Nov 2025

A virtual platform for automated hybrid organic-enzymatic synthesis planning

The results indicate that this fully automated, open-source system holds potential value for improving the efficiency and sustainability of molecular synthesis, and the integration of organic and enzymatic synthesis enhances molecule construction efficiency.

Xiaorui Wang, Xiaodan Yin, Xujun Zhang et al. · 0 citations
#machine learning Open access Apr 2026

Accurate and task-agnostic modeling of enzymatic reactions through multimodal relational learning

ERAM aligns pre-trained molecular representations from Protein Language Model with the knowledge of enzyme catalysis by modeling enzymatic reactions as multi-relational data, and demonstrates its potential as a versatile and effective tool for enzyme catalysis research.

Yuansheng Huang, Lanqing Li, Wenjia Qian et al. · 2 citations
Aug 2026

Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.

An integrated virtual screening strategy based on molecular fingerprint similarity, pharmacophore models, molecular docking, and molecular dynamics simulation is proposed and three promising lead compounds targeting RIPK3 for AD treatment are offered.

Chenggong Fu, Qin Li, Yuwei Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.